Cellulitis Completed Phase 3 Trials for Imipenem (DB01598)

Also known as: Cellulitis, unspecified

IndicationStatusPhase
DBCOND0014773 (Cellulitis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00619710Complicated Skin and Skin Structure InfectionsTreatment